Not logged in Share Save
Share Save
Outcomes and salvage strategies for large B-cell lymphoma progressing after second-line CAR T-cell therapy: A DESCAR-T study from the LYSA group Sesques, Pierre; Manson, Guillaume; Cartron, Guillaume; Gros, Francois-Xavier; Morschhauser, Franck; Castilla-Llorente, Cristina; Brisou, Gabriel; Bories, Pierre; Thieblemont, Catherine; La Rochelle, Laurianne Drieu; Tessoulin, Benoit; Andre, Axel; Rossi, Cedric; Paillassa, Jerome; Guidez, Stephanie; Capes, Antoine; Herbreteau, Laura; Choquet, Sylvain; Bay, Jacques-Olivier; Chauchet, Adrien; Lebras, Laure; Claves, Fabien; Abraham, Julie; Malfuson, Jean-Valere; Rubio, Marie-Therese; Decroocq, Justine; Fornecker, Luc-Matthieu; Damaj, Gandhi; Fouillet, Ludovic; Joris, Magalie; Loschi, Michael; Hermine, Olivier; Hafirassou, Hadia; Van Zele, Emelie; Dupont, Vivien; Le Gouill, Steven; Houot, Roch; Camus, Vincent Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Return to employment outcomes in patients with multiple myeloma Lilli, Nicoletta Libera; Pequin, Manon; Dulondel, Leana; Blin, Nicolas; Gastinne, Thomas; Tessoulin, Benoit; Dubruille, Viviane; Antier, Chloe; Roquelaure, Yves; Moreau, Philippe; Porro, Bertrand; Touzeau, Cyrille Share Save
Share Save
Share Save
Share Save
Share Save
Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial (vol 6, pg 528, 2025) Kim, Won Seog; Kim, Tae Min; Cho, Seok-Goo; Jarque, Isidro; Iskierka-Jazdzewska, Elzbieta; Poon, Li Mei; Prince, H. Miles; Zhang, Huilai; Cao, Junning; Zhang, Mingzhi; Tessoulin, Benoit; Oh, Sung Yong; Lim, Francesca; Carpio, Cecilia; Tan, Tran-Der; Ayyappan, Sabarish; Gutierrez, Antonio; Cai, Jingxian; Ufkin, Melanie; Shariff, Saleem; Brouwer-Visser, Jurriaan; Chaudhry, Aafia; Mohamed, Hesham; Ambati, Srikanth; Walewski, Jan Share Save
Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study (vol 109, pg 2297, 2024) Iannitto, Emilio; Ferrero, Simone; Bommier, Come; Drandi, Daniela; Ferrante, Martina; Bouabdallah, Krimo; Carras, Sylvain; Gini, Guido; Camus, Vincent; Mancuso, Salvatrice; Marcheselli, Luigi; Ferrari, Angela; Merli, Michele; Tessoulin, Benoit; Stelitano, Caterina; Beldjord, Kheira; Roti, Giovanni; Jardin, Fabrice; Castagnari, Barbara; Palombi, Francesca; Baseggio, Lucile; Traverse-Glehen, Alexandra; Tripodo, Claudio; Liberati, Anna Marina; Parolini, Margherita; Usai, Sara; Patti, Caterina; Federico, Massimo; Musso, Maurizio; Ladetto, Marco; Zucca, Emanuele; Thieblemont, Catherine Share Save
Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma (vol 35, pg 1039, 2024) Kim, T. M.; Taszner, M.; Novelli, S.; Cho, S. -G; Villasboas, J. C.; Merli, M.; Jimenez-Ubieto, A.; Tessoulin, B.; Poon, L. M.; Tucker, D.; Walewski, J.; Yi, S.; Song, Y.; Chong, G.; Bachy, E.; Guidez, S.; Alonso, A.; Jagadeesh, D.; Zhang, W.; Magnano, L.; Iskierka-Jazdzwska, E.; Tani, M.; Shen, B.; Uppala, A.; Zhu, M.; Shariff, S.; Brouwer-Visser, J.; Chaudhry, A.; Mohamed, H.; Ambati, S.; Luminari, S. Share Save
Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
